Global life sciences company Cytiva is opening a new 7,400 square meter manufacturing facility in Grens, Switzerland on May 31, 2022. The site will manufacture single use kits for the Sepax and Sefia cell processing systems, as well as consumables for Xuri cell expansion systems. It will also serve as a Center of Excellence for Cytiva’s cell and gene therapy business and will be a base for European customer training programs. The site will be home to 250 associates. An opening ceremony will b...